The biotech company Nuage Therapeutics, a member of CATALONIA.HEALTH, has received a capital injection of €1.8 million. 

The latest edition of the Hard Reg Café, promoted by Catalonia.health, focused on innovation, specifically on the new ISO 56001:2024 standard for Innovation Management Systems.

Sold out to participate in the conversation at this May's edition of the CEO Council, with Fina Lladós as the special guest. The new CEO of Catalonia.health, Arantxa Sanz, was in charge of the welcome, accompanied by Mariona Serra, president. This was the second edition of 2025, after the conversation  with Ignasi Belda, of these small-committee discussion meetings exclusively for Catalonia.health members.

The Vall de Hebron Research Institute (VHIR), a member of CATALONIA.HEALTH, has obtained ISO 56001:2024 certification, which certifies excellence in innovation management.

Professionals from Hospital del Mar have shared different clinical needs they have identified in their day-to-day care with Catalonia.health companies, as well as with other companies in the Catalan health sector, who have attended a new edition of the “Hospital Connection”. The initiative, promoted by Catalonia.health and its Internal Innovation Committee, aims to generate synergies and encourage the development of joint solutions that reach health professionals and patients as soon as possible.

The 3DBBT consortium, led by the MAV Cluster and formed by this entity and CATALONIA. HEALTH, the companies DAN*NA and Perdigó, and the foundations Elisava and CIM-UPC, is finalising the design of synthetic bone tissue through 3D printing, which will facilitate the development of new bone models with a high level of bio-realism and will allow real access to personalised medicine.

The consultancy GENESIS Biomed, a member of CATALONIA.HEALTH, held its 2025 Annual Symposium at the Auditori Antoni Caparrós of the Barcelona Science Park, which brought together more than 110 professionals from the local and national ecosystem, from public entities and private companies.

The venture capital company Ysios Capital, a member of CATALONIA.HEALTH, has announced that its investee company, ReproNovo has closed a $65 milions Series A financing round.

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has been selected to receive a €13 million grant from the Centre for the Development of Industrial Technology (CDTI). 

The neurotechnology company INBRAIN Neuroelectronics, a member of CATALONIA.HEALTH, has received a 4 million euros’ grant from the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative, a national programme to support the most revolutionary innovation in microelectronics, semiconductors and deeptech.

The public-private consortium formed by the biopharmaceutical company Oniria Therapeutics, a member of CATALONIA.HEALTH, the Spanish National Research Council (CSIC) and the Vall d'Hebron Institute of Oncology (VHIO) has obtained 2 million euros of funding from the Ministry of Science, Innovation and Universities of Spain and the European Union, through the Public-Private Collaboration Program 2023. 

CATALONIA.HEALTH incorpora a Arantxa Sanz com a directora general de l’entitat. Amb aquest nou lideratge, s’inicia una nova etapa enfocada a consolidar el seu posicionament dins l’ecosistema i a reforçar les aliances entre el món científic, empresarial i institucional.

The medical diagnostics company Deepull, a member of CATALONIA.HEALTH, has announced the closing of a €50 million Series C financing round. 

New studies emphasize how peptide-based launches, the core of the Gate2Brain technological platform, a member of CATALONIA.HEALTH, are poised to revolutionise drug administration through the blood-brain barrier. 

Why are biotechs booming in Barcelona? Nature, the most prestigious scientific journal in the world, has highlighted three biotech startups based in Barcelona and members of CATALONIA.HEALTH, Nuage Therapeutics, Ona Therapeutics and SpliceBio.

The Board of Trustees of the Josep Carreras Leukaemia Research Institute, a member of CATALONIA.HEALTH, has approved the appointment of Ari Melnick as the new Director of the centre.

The R&D pharma company Accure Therapeutics, a member of CATALONIA.HEALTH, has received two grants totalling 1.6 million of dollars, $1.12M in grants awarded by The Michael J. Fox Foundation (MJFF) and $0.48M by the Luxembourg National Research Fund (FNR) for two separate development programs on its drug candidate ACT-02.

The venture capital company Ysios Capital, a member of CATALONIA.HEALTH, has announced that its investee company, Neurona Therapeutics, has closed a funding round of 102 million dollars. 

The CEO of the biotech company specialized in enhancing the female fertility, Oxolife, a member of CATALONIA.HEALTH, Agnès Arbat, wins the 2025 European Prize for Women Innovators in the Women Innovator category. 

Biotechnology company Gain Therapeutics, member of CATALONIA.HEALTH, announce the dosing of the first participant with Parkinson’s disease in its Phase 1b clinical trial of GT-02287